Spasticity and botulinum toxin in 2003. An update;Spasticité et toxine botulique. Le point en 2003

Neurochirurgie

Volumn 49, Issue 2-3 II, 2003, Pages 265-270

  Feve A ^a  

^a Léopold Bellan Hospital   (France)

Author keywords

Botulinum toxin; Cerebral palsy; Spasticity; Stroke; Varus equin foot

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B; PLACEBO;

CEREBRAL PALSY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG COST; DRUG EFFICACY; DRUG MARKETING; DRUG MECHANISM; GAIT DISORDER; HEALTH CARE COST; HUMAN; LIMB; MULTIPLE SCLEROSIS; QUALITY OF LIFE; SPASTICITY; SPHINCTER; SPINAL CORD INJURY; STROKE; TREATMENT INDICATION; TREATMENT OUTCOME;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; CEREBRAL PALSY; CLINICAL TRIALS; HUMANS; MULTIPLE SCLEROSIS; MUSCLE SPASTICITY;

EID: 0038743145     PISSN: 00283770     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. ANSVED T, ODERGREN T, BORG K. Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia. Neurology 1997; 48: 1440-1442.
2. BAKHEIT AM, THILMANN AF, WARD AB, POEWE W, WISSEL J, MULLER J et al. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 2000; 31: 2402-2406.
3. BHAKTA BB, COZENS JA, CHAMBERLAIN MA, BAMFORD JM. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. J Neurol Neurosurg Psychiatry 2000; 69: 217-221.
4. BOHLEGA S, CHAUD P, JACOB PC. Botulinum toxin A in the treatment of lower limb spasticity in hereditary spastic paraplegia. Mov Disord 1995; 10: 399 (abstract).
5. BRASHEAR A, GORDON MF, ELOVIC E, KASSICIEH VD, MARCINIAK C, Do M et al., for the Botox Post-Stroke Spasticity Study Group. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 2002; 347: 395-400.
6. BORG-STEIN J, PINE ZM, MILLER JR, BRIN MF. Botulinum toxin for the treatment of spasticity in multiple sclerosis: new observations. Am J Phys Med Rehabil 1993; 72: 364-368.
7. DENGLER R, NEYER U, WOHLFARTH K, BETTIG U, JANZIK HH. Local botulinum toxin in the treatment of spastic foot drop. J Neurol 1992; 239: 375-378.
8. De PAVA A, MEUNIER FA, MOLG-AOKI KR, DOLLY JO. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA 1999; 96: 3200-3205.
9. DYKSTRA DD, SIDI AA. Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double blind study. Arch Phys Med Rehabil 1990; 71: 24-26.
10. ELEOPRA R, TUGNOLI V, DE GRANDIS D. The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans. Mov Disord 1997; 12: 89-94.
11. FILIPPI GM, ERRICO P, SANTARELLI R, BAGOLINI B, MANNI E. Botulinum toxin effects on rat jaw muscle spindles. Acta Otolaryngol 1993; 113: 400-404.
12. GRAZKO MA, POLO KB, JABBARI B. Botulinum toxin A for spasticity: muscle spasms, and rigidity. Neurology 1995; 45: 712-717.
13. HYMAN N, BARNES M, BHAKTA B, COZENS A, BAKHEIT M, KRECZY-KLEEDORFER B et al. Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double-blind, placebo-controlled, dose-ranging study. J Neurol Neurosurg Psychiatr 2000; 68: 707-712.
14. RACETTE BA, LOPATE G, GOOD L, SAGITTO S, PERLMUTTER JS. Ptosis as a remote effect of therapeutic botulinum toxin B injection. Neurology 2002; 59: 1445-1447.
15. RADENSKY PW, ARCHER J, DOURNAUX SF, O'BRIEN CF. The estimated cost of managing focal spasticity: a physician practice patterns survey. Neurorehabil Neural Repair 2001; 15: 57-68.
16. SHAARI CM, GEORGE E, WU BL, BILLER HF, SANDERS I. Quantifying he spread of botulinum toxin through muscle fascia. Laryngoscope 1991; 101: 960-964.
17. st ed. New York: Academic Press, 1989: 153-178.
18. SIMPSON DM, ALEXANDER DN, O'BRIEN CF, TAGLIATI M, ASWAD AS, LEON JM et al. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double blind, placebo-controlled trial. Neurology 1996; 46: 1306-1310.
19. SNOW BJ, TSUI JK, BHATT MH, VARELAS M, HASHIMOTO SA, CALNE DB. Treatment of spasticity with botulinum toxin; a double blind study. Ann Neurol 1990; 28: 512-515.
20. TAKENAGA S, KAWAHIGASHI Y, SONODA Y, HORIKIRI T, HIRATA K, ARIMURA K et al. Treatment of spastic paraparesis with botulinum toxin with reference to beneficial effects, disease severity and long term treatment. Ronsho Shinkeigaku 1995; 35: 251-255.